Published online Feb 16, 2026. doi: 10.4253/wjge.v18.i2.113699
Revised: October 2, 2025
Accepted: December 17, 2025
Published online: February 16, 2026
Processing time: 155 Days and 19.5 Hours
The mediastinum comprises vital anatomical structures and can be affected by diverse benign and malignant pathologies. Imaging modalities such as computed tomography, magnetic resonance imaging, and positron emission tomography assist in initial evaluation, but histopathological confirmation remains the diag
To assess the diagnostic yield of EUS-guided FNB in evaluating mediastinal pathologies and its role in guiding management in low- and middle-income coun
This single-centre retrospective study was conducted at Aga Khan University Hospital, Karachi, from June 2020 to June 2024, involving adults (≥ 18 years) who underwent EUS-guided FNB for mediastinal pathology. Franseen needles with capillary suction were used without rapid on-site evaluation, yielding adequate histopathological samples in all cases. Data included demographics, radiological, procedural, and histopathological details, treatment, and outcomes. Statistical analysis was performed using Statistical Package for the Social Sciences version 23, with receiver operating characteristic curve analysis used to assess the diagnostic performance of EUS-guided FNB.
A total of 77 patients (mean age: 54.4 ± 14.1 years; 55.8% male) underwent EUS-guided FNB for mediastinal pathology. Most (81.8%) were symptomatic, with lymphadenopathy or masses mostly detected on computed tomography (79.2%). Adequate tissue diagnosis was achieved in 94.8%; 41.6% were malignant. EUS-FNB showed 88.9% (95% confidence interval: 74.7-95.6) sensitivity, 100% (95% confidence interval: 91.4-100) specificity, and an area under the curve of 0.94. Malignant cases had significantly larger lymph nodes (2.3 ± 0.9 cm vs 1.57 ± 0.6 cm, P = 0.009) and masses (median 7.8 cm vs 4.2 cm, P = 0.001). Most EUS procedures (96.1%) were performed using a 22G needle. The mean number of needle passes was 2.1 ± 0.8. No post-procedure complications occurred. Common diagnoses included reactive lymphoid tissue (20.8%), tuberculosis (14.3%), and lymphoma (11.7%). Conservative therapy was the most common treatment (28.6%). Overall, 68.8% survived and 13.0% died.
EUS-guided FNB is a highly accurate and safe modality for diagnosing mediastinal pathologies, offering excellent diagnostic yield without procedure-related complications and effectively guiding management of both benign and malignant cases.
Core Tip: Endoscopic ultrasound-guided fine-needle biopsy (EUS-FNB) is a minimally invasive technique that enables accurate tissue sampling of mediastinal lesions. In this single-centre study from Pakistan, EUS-FNB demonstrated excellent diagnostic performance, with 94.8% diagnostic yield, 88.9% sensitivity, and 100% specificity, while maintaining a strong safety profile without procedure-related complications. The study highlights the value of EUS-FNB in guiding management of both benign and malignant mediastinal pathologies and addressing a critical evidence gap in low- and middle-income country settings, where data remain limited.
